Search
Replimune Group Inc
REPLAdd to Watchlist
9.700USD
-0.760-7.27%
Close 07-24 16:00（ET）Quotes delayed by 15 min
772.42MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
8
analysts
Hold
Current Rating
9.273
Target Price
-11.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Replimune Group Inc
REPL
8
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Replimune Group Inc's price target?
Analysts forecast that Replimune Group Inc's price target is USD 12.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 2.00.
How have Replimune Group IncREPL's recent earnings per share performed?
The market expectation was USD -0.77, while Replimune Group IncREPL's earnings per share (EPS) for the previous quarter was USD -0.77. EPS for the next quarter is expected at USD -0.68.
What is the analyst rating for Replimune Group Inc?
Based on the ratings of Replimune Group Inc's stock from 8 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.